About Nath Bio-Genes (India) Limited
Data last updated: 22 December 2025
Nath Bio-Genes (India) Limited is a public limited company based in Aurangabad, Maharashtra, India. It specialises in seed production and distribution, a part of the broader agriculture sector. Incorporated on 14 July 1993, the company has been in operation for over 33 years.
Registered with ROC Mumbai under CIN L01110MH1993PLC072842. Listed on BSE: 537291 and NSE: NATHBIOGEN.
Capital: an authorised share capital of ₹21 Cr and a paid-up capital of ₹19 Cr. It is led by directors including Vadla Nagabhushanam and Akash Nandkishor Kagliwal.
Last AGM: 22 August 2025. Financial statements filed for year ended 31 March 2025. Office: Nath House Nath Road, Aurangabad, Maharashtra, India – 431005.
As per the financials filed for FY 2025, the company reported a revenue of ₹369.45 Cr, a growth of 11% compared to the previous year.
The company has a workforce of approximately 417 employees as per the latest available data.
The company is associated with 1 brand - Nath Bio-Genes. As per MCA filings, the company has open charges of ₹114.1 Cr and satisfied charges of ₹183.2 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website nathbiogenes.com.
-
Email*****@*****.com
-
Telephone+91-****-******
-
Website
-
Social Media
-
Registered AddressNath House Nath Road, Aurangabad, Maharashtra, India – 431005
-
IndustryAgriculture, Seed Production & Distribution
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Nath Bio-Genes (India) Limited
Nath Bio-Genes (India) Limited has one previous CIN (Corporate Identification Number): U01110MH1993PLC072842. The current CIN is L01110MH1993PLC072842, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L01110MH1993PLC072842 | Current |
| U01110MH1993PLC072842 | Previous |
Associated Brands with Nath Bio-Genes (India) Limited
Nath Bio-Genes (India) Limited operates one associated brand: Nath Bio-Genes. These brands represent Nath Bio-Genes (India) Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Company that develops, produces, and markets hybrid and seeds for various crops, with a focus on improving crop yields | nathbiogenes.com |
Business Activity of Nath Bio-Genes (India) Limited
Nath Bio-Genes (India) Limited is engaged in the principal business activity of agriculture, forestry, fishing, with detailed activities including support activities to agriculture and other activities including hunting.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| A | Agriculture, forestry, fishing | A4 | Support activities to agriculture and Other Activities including hunting | ********* |
Auditor Details of Nath Bio-Genes (India) Limited
Nath Bio-Genes (India) Limited is audited by GAUTAM N ASSOCIATES, CHARTERED ACCOUNTANTS (ICAI peer reviewed, certificate valid till 2027-06-30) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.
| Name | Financial year | Audit opinion |
|---|---|---|
| GAUTAM N ASSOCIATES, CHARTERED ACCOUNTANTS (ICAI peer reviewed, certificate valid till 2027-06-30) | FY 2026 | Declaration of unmodified opinion |
Board of Directors of Nath Bio-Genes (India) Limited
Nath Bio-Genes (India) Limited is currently managed by 9 directors, with 19 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vadla Nagabhushanam | Director | 07 Nov 2020 | 5 Years 8 Months | Current |
|
Akash Nandkishor Kagliwal
Also directs:
Emerald Seeds Private Limited, Paithan Mega Food Park Private Limited, Nathnirman Private Limited and 5 more
|
Director | 22 Apr 2023 | 3 Years 2 Months | Current |
|
Jeevanlata Nandkishor Kagliwal
Also directs:
Agri-Tech (India) Limited, Nath Bio-Technologies Limited, Ferry Fax Farms Pvt Ltd and 5 more
|
Director | 30 May 2019 | 7 Years 1 Months | Current |
| Madhukar Dhondiraj Deshpande | Director | 10 Feb 2021 | 5 Years 4 Months | Current |
| Hitesh Rajnikant Purohit | Director | 30 Mar 2022 | 4 Years 3 Months | Current |
| Satish Laxminarayan Kagliwal | Managing Director | 29 Mar 2000 | 26 Years 3 Months | Current |
Financials of Nath Bio-Genes (India) Limited FY 2026 filings available
Nath Bio-Genes (India) Limited reported revenue of ₹445.1 Cr (up 21.98% YoY) for FY 2026. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Revenue from Operations | ₹445.1 Cr | ₹364.91 Cr | ₹332.62 Cr | ₹301.36 Cr |
| Other Income | ₹7.81 Cr | ₹4.55 Cr | ₹62.66 Lakh | ₹55.35 Lakh |
| Total Income | ₹452.91 Cr | ₹369.45 Cr | ₹333.25 Cr | ₹301.92 Cr |
| Cost of Materials Consumed | ₹306.18 Cr | ₹225.54 Cr | ₹142.47 Cr | ₹117.32 Cr |
| Purchases of Stock-in-Trade | ₹7.7 Cr | ₹12.73 Cr | ₹12.26 Cr | ₹5.31 Cr |
| Changes in Inventories | -₹112.38 Cr | -₹102.73 Cr | -₹21.16 Cr | ₹11.98 Cr |
| Employee Benefit Expense | ₹35.79 Cr | ₹32.5 Cr | ₹28.25 Cr | ₹23.32 Cr |
| Finance Costs | ₹15.99 Cr | ₹10.48 Cr | ₹9.11 Cr | ₹10.12 Cr |
| Depreciation & Amortisation | ₹3.96 Cr | ₹3.82 Cr | ₹3.26 Cr | ₹3.01 Cr |
| Other Expenses | ₹155.37 Cr | ₹147.06 Cr | ₹120.94 Cr | ₹94.69 Cr |
| Total Expenses | ₹412.62 Cr | ₹329.41 Cr | ₹295.13 Cr | ₹265.75 Cr |
| Profit Before Exceptional Items & Tax | ₹40.3 Cr | ₹40.04 Cr | ₹38.12 Cr | ₹36.16 Cr |
| Exceptional Items | ₹6.01 Cr | ₹54.03 Lakh | ₹3.45 Cr | ₹0 |
| Profit Before Tax | ₹46.3 Cr | ₹40.58 Cr | ₹41.57 Cr | ₹36.16 Cr |
| Total Tax Expense | ₹4.67 Cr | ₹1.98 Cr | ₹1.95 Cr | ₹1.15 Cr |
| Net Profit | ₹41.63 Cr | ₹38.6 Cr | ₹39.62 Cr | ₹35.03 Cr |
| attributable to Owners | ₹0 | ₹0 | ₹0 | - |
| attributable to NCI | ₹0 | ₹0 | ₹0 | - |
| Other Comprehensive Income | -₹1.76 Cr | -₹33.05 Lakh | ₹92.77 Lakh | ₹2.06 Lakh |
| Total Comprehensive Income | ₹39.87 Cr | ₹38.27 Cr | ₹40.55 Cr | ₹35.05 Cr |
| EBITDA (computed) | ₹60.25 Cr | ₹54.34 Cr | ₹50.49 Cr | ₹49.3 Cr |
| Basic EPS | ₹20.98 | ₹0.00 | ₹21.34 | ₹18.42 |
| Diluted EPS | ₹20.98 | ₹0.00 | ₹21.34 | ₹18.42 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Total Assets | ₹1,097.42 Cr | ₹1,026.21 Cr | ₹880.23 Cr | ₹792.8 Cr |
| Non-current Assets | ₹318.56 Cr | ₹336.2 Cr | ₹308.57 Cr | ₹271.97 Cr |
| Current Assets | ₹778.86 Cr | ₹690.01 Cr | ₹571.66 Cr | ₹520.83 Cr |
| Property, Plant & Equipment | ₹243.8 Cr | ₹243.19 Cr | ₹240.65 Cr | ₹233.96 Cr |
| Inventories | ₹450.55 Cr | ₹338.02 Cr | ₹230.31 Cr | ₹207.85 Cr |
| Trade Receivables | ₹85.41 Cr | ₹88.9 Cr | ₹94.31 Cr | ₹97.31 Cr |
| Cash & Equivalents | ₹76 Cr | ₹88.9 Cr | ₹77.41 Cr | ₹38 Cr |
| Equity (Net Worth) | ₹680.46 Cr | ₹644.39 Cr | ₹609.92 Cr | ₹573.17 Cr |
| Equity Share Capital | ₹19 Cr | ₹19 Cr | ₹19 Cr | ₹19 Cr |
| Borrowings (Non-current) | ₹17.32 Cr | ₹12.98 Cr | ₹0 | ₹40.32 Lakh |
| Borrowings (Current) | ₹121.18 Cr | ₹109.52 Cr | ₹105.48 Cr | ₹104.81 Cr |
| Total Debt (computed) | ₹138.5 Cr | ₹122.5 Cr | ₹105.48 Cr | ₹105.21 Cr |
| Current Liabilities | ₹394.7 Cr | ₹365.3 Cr | ₹262.45 Cr | ₹216.45 Cr |
| Total Liabilities | ₹416.96 Cr | ₹381.82 Cr | ₹270.31 Cr | ₹219.62 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Operating Cash Flow | -₹12.57 Cr | ₹17.58 Cr | ₹70.28 Cr | ₹38.37 Cr |
| Investing Cash Flow | ₹3.46 Cr | -₹3.96 Cr | -₹27.4 Cr | -₹2.88 Cr |
| Financing Cash Flow | -₹3.81 Cr | -₹2.13 Cr | -₹4.51 Cr | -₹1.67 Cr |
| Capital Expenditure | ₹3.01 Cr | ₹7.92 Cr | ₹8.39 Cr | ₹2.48 Cr |
| Free Cash Flow (computed) | -₹15.58 Cr | ₹9.66 Cr | ₹61.89 Cr | ₹35.89 Cr |
| Dividends Paid | ₹3.8 Cr | ₹3.8 Cr | -₹3.8 Cr | ₹3.8 Cr |
| Net Change in Cash | -₹12.93 Cr | ₹11.49 Cr | ₹38.37 Cr | ₹33.82 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹51.59 Cr | ₹65.96 Cr | ₹43.85 Cr | ₹283.7 Cr | ₹51.97 Cr | ₹36.87 Cr | ₹32.19 Cr | ₹243.88 Cr | ₹43.04 Cr | ₹31.74 Cr | ₹22.57 Cr | ₹235.28 Cr |
| Other Income | ₹2.38 Cr | ₹1.74 Cr | ₹1.93 Cr | ₹1.76 Cr | ₹3.86 Cr | ₹47.82 Lakh | ₹7.55 Lakh | ₹13.02 Lakh | ₹41.07 Lakh | ₹3.74 Lakh | ₹6.15 Lakh | ₹11.7 Lakh |
| Total Income | ₹53.97 Cr | ₹67.69 Cr | ₹45.78 Cr | ₹285.46 Cr | ₹55.83 Cr | ₹37.35 Cr | ₹32.27 Cr | ₹244.01 Cr | ₹43.45 Cr | ₹31.78 Cr | ₹22.63 Cr | ₹235.4 Cr |
| Cost of Materials Consumed | ₹69.2 Cr | ₹106.33 Cr | ₹21.8 Cr | ₹108.85 Cr | ₹101.6 Cr | ₹86.87 Cr | ₹68.51 Lakh | ₹66.39 Cr | ₹59.02 Cr | ₹8.36 Cr | ₹5.66 Cr | ₹69.42 Cr |
| Purchases of Stock-in-Trade | ₹2.05 Cr | ₹1.02 Cr | ₹27.7 Lakh | ₹4.35 Cr | ₹95.3 Lakh | ₹5.21 Cr | ₹3.75 Cr | ₹2.82 Cr | ₹3.71 Cr | ₹2.42 Cr | ₹4.08 Cr | ₹2.07 Cr |
| Changes in Inventories | -₹55.45 Cr | -₹78.57 Cr | -₹4.97 Cr | ₹26.62 Cr | -₹84.87 Cr | -₹79.59 Cr | ₹8.03 Cr | ₹53.71 Cr | -₹71.79 Cr | ₹3.35 Cr | -₹5.51 Cr | ₹51.29 Cr |
| Employee Benefit Expense | ₹4.21 Cr | ₹11.61 Cr | ₹10.39 Cr | ₹9.59 Cr | ₹6.34 Cr | ₹10.49 Cr | ₹8.94 Cr | ₹6.74 Cr | ₹7.17 Cr | ₹5.99 Cr | ₹7.85 Cr | ₹7.19 Cr |
| Finance Costs | ₹4.59 Cr | ₹4.54 Cr | ₹3.66 Cr | ₹3.2 Cr | ₹1.37 Cr | ₹3.9 Cr | ₹2.98 Cr | ₹2.24 Cr | ₹1.07 Cr | ₹2.84 Cr | ₹2.44 Cr | ₹2.76 Cr |
| Depreciation & Amortisation | ₹1.03 Cr | ₹97.53 Lakh | ₹98.72 Lakh | ₹97.5 Lakh | ₹1.34 Cr | ₹82.5 Lakh | ₹82.5 Lakh | ₹82.5 Lakh | ₹98.12 Lakh | ₹76 Lakh | ₹76 Lakh | ₹76 Lakh |
| Other Expenses | ₹27.11 Cr | ₹22 Cr | ₹10.25 Cr | ₹96 Cr | ₹27.53 Cr | ₹5.86 Cr | ₹5.98 Cr | ₹77.69 Cr | ₹41 Cr | ₹5.97 Cr | ₹4.96 Cr | ₹68.5 Cr |
| Total Expenses | ₹52.74 Cr | ₹67.9 Cr | ₹42.39 Cr | ₹249.59 Cr | ₹54.26 Cr | ₹33.56 Cr | ₹31.18 Cr | ₹210.41 Cr | ₹41.16 Cr | ₹29.69 Cr | ₹20.25 Cr | ₹202 Cr |
| Profit Before Exceptional Items & Tax | ₹1.23 Cr | -₹20.82 Lakh | ₹3.39 Cr | ₹35.88 Cr | ₹1.57 Cr | ₹3.79 Cr | ₹1.09 Cr | ₹33.6 Cr | ₹2.28 Cr | ₹2.09 Cr | ₹2.38 Cr | ₹33.4 Cr |
| Exceptional Items | ₹1.26 Cr | ₹2.69 Cr | ₹2.06 Cr | ₹2.06 Cr | ₹54.03 Lakh | ₹0 | ₹0 | ₹0 | ₹94.9 Lakh | ₹2.5 Cr | ₹0 | ₹0 |
| Profit Before Tax | ₹2.49 Cr | ₹2.48 Cr | ₹5.46 Cr | ₹37.94 Cr | ₹2.11 Cr | ₹3.79 Cr | ₹1.09 Cr | ₹33.6 Cr | ₹3.23 Cr | ₹4.59 Cr | ₹2.38 Cr | ₹33.4 Cr |
| Total Tax Expense | ₹2.5 Cr | ₹87.28 Lakh | ₹64.11 Lakh | ₹65.97 Lakh | ₹62.73 Lakh | ₹1.14 Cr | -₹2.75 Lakh | ₹24.53 Lakh | ₹61.51 Lakh | ₹76.57 Lakh | ₹34.53 Lakh | ₹22.01 Lakh |
| Net Profit | -₹92,000 | ₹1.61 Cr | ₹2.75 Cr | ₹37.28 Cr | ₹1.48 Cr | ₹2.65 Cr | ₹1.11 Cr | ₹33.35 Cr | ₹2.62 Cr | ₹3.83 Cr | ₹2.07 Cr | ₹33.18 Cr |
| attributable to Owners | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | - | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| attributable to NCI | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | - | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Other Comprehensive Income | -₹1.5 Cr | ₹9.15 Lakh | -₹8.75 Lakh | -₹8 Lakh | ₹68.12 Lakh | -₹11.69 Lakh | -₹10.96 Lakh | -₹12.42 Lakh | ₹94.27 Lakh | ₹56,000 | -₹42.55 Lakh | ₹0 |
| Total Comprehensive Income | -₹1.51 Cr | ₹1.7 Cr | ₹2.67 Cr | ₹37.2 Cr | ₹2.16 Cr | ₹2.53 Cr | ₹1 Cr | ₹33.23 Cr | ₹3.56 Cr | ₹3.84 Cr | ₹1.64 Cr | ₹33.18 Cr |
| EBITDA (computed) | ₹6.85 Cr | ₹5.31 Cr | ₹8.04 Cr | ₹40.05 Cr | ₹4.28 Cr | ₹8.51 Cr | ₹4.89 Cr | ₹36.67 Cr | ₹4.34 Cr | ₹5.68 Cr | ₹5.58 Cr | ₹36.93 Cr |
| Basic EPS | ₹-0.79 | ₹0.84 | ₹1.40 | ₹19.58 | ₹0.00 | ₹1.33 | ₹0.53 | ₹17.49 | ₹1.87 | ₹2.02 | ₹0.86 | ₹17.47 |
| Diluted EPS | ₹-0.79 | ₹0.84 | ₹1.40 | ₹19.58 | ₹0.00 | ₹1.33 | ₹0.53 | ₹17.49 | ₹1.87 | ₹2.02 | ₹0.86 | ₹17.47 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹431.6 Cr | ₹362.31 Cr | ₹332.62 Cr | ₹301.29 Cr | ₹278.36 Cr | ₹307.56 Cr | ₹279.89 Cr |
| Other Income | ₹7.81 Cr | ₹4.73 Cr | ₹65.34 Lakh | ₹56.04 Lakh | ₹1.85 Cr | ₹1.67 Cr | ₹1.82 Cr |
| Total Income | ₹439.41 Cr | ₹367.04 Cr | ₹333.28 Cr | ₹301.85 Cr | ₹280.22 Cr | ₹309.23 Cr | ₹281.71 Cr |
| Cost of Materials Consumed | ₹297.69 Cr | ₹217.55 Cr | ₹142.45 Cr | ₹117.3 Cr | ₹115.42 Cr | ₹148.9 Cr | ₹167.15 Cr |
| Purchases of Stock-in-Trade | ₹7.52 Cr | ₹12.51 Cr | ₹11.02 Cr | ₹5.31 Cr | ₹3.56 Cr | ₹8.96 Cr | ₹7.35 Cr |
| Changes in Inventories | -₹113.89 Cr | -₹96.66 Cr | -₹19.92 Cr | ₹11.98 Cr | ₹4.99 Cr | -₹21.76 Cr | -₹48.25 Cr |
| Employee Benefit Expense | ₹33.33 Cr | ₹30.31 Cr | ₹27.98 Cr | ₹23.23 Cr | ₹24.78 Cr | ₹23.69 Cr | ₹18.74 Cr |
| Finance Costs | ₹13.31 Cr | ₹9.65 Cr | ₹9.1 Cr | ₹10.12 Cr | ₹10.61 Cr | ₹8.82 Cr | ₹6.55 Cr |
| Depreciation & Amortisation | ₹3.95 Cr | ₹3.79 Cr | ₹3.26 Cr | ₹3.01 Cr | ₹3.08 Cr | ₹2.82 Cr | ₹1.45 Cr |
| Other Expenses | ₹154.41 Cr | ₹145.76 Cr | ₹120.7 Cr | ₹94.58 Cr | ₹92.37 Cr | ₹81.06 Cr | ₹80.22 Cr |
| Total Expenses | ₹396.32 Cr | ₹322.91 Cr | ₹294.6 Cr | ₹265.53 Cr | ₹254.82 Cr | ₹252.48 Cr | ₹233.2 Cr |
| Profit Before Exceptional Items & Tax | ₹43.09 Cr | ₹44.12 Cr | ₹38.67 Cr | ₹36.32 Cr | ₹25.4 Cr | ₹56.75 Cr | ₹48.51 Cr |
| Exceptional Items | ₹6.01 Cr | ₹0 | ₹3.45 Cr | ₹0 | -₹88.78 Cr | ₹0 | ₹0 |
| Profit Before Tax | ₹49.1 Cr | ₹44.12 Cr | ₹42.12 Cr | ₹36.32 Cr | -₹63.39 Cr | ₹56.75 Cr | ₹48.51 Cr |
| Total Tax Expense | ₹4.67 Cr | ₹1.98 Cr | ₹1.95 Cr | ₹1.15 Cr | ₹3.95 Cr | ₹1.09 Cr | -₹1.98 Cr |
| Net Profit | ₹44.43 Cr | ₹42.14 Cr | ₹40.18 Cr | ₹35.17 Cr | -₹67.34 Cr | ₹55.66 Cr | ₹50.48 Cr |
| Other Comprehensive Income | ₹7.82 Lakh | -₹33.04 Lakh | ₹92.77 Lakh | ₹2.06 Lakh | ₹0 | ₹0 | -₹44.75 Lakh |
| Total Comprehensive Income | ₹44.5 Cr | ₹41.81 Cr | ₹41.1 Cr | ₹35.19 Cr | -₹67.34 Cr | ₹55.66 Cr | ₹50.04 Cr |
| EBITDA (computed) | ₹60.35 Cr | ₹57.56 Cr | ₹51.04 Cr | ₹49.45 Cr | ₹39.09 Cr | ₹68.39 Cr | ₹56.51 Cr |
| Basic EPS | ₹23.42 | ₹0.00 | ₹21.63 | ₹18.50 | ₹-35.43 | ₹29.29 | ₹26.33 |
| Diluted EPS | ₹23.42 | ₹0.00 | ₹21.63 | ₹18.50 | ₹-35.43 | ₹29.29 | ₹26.33 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Total Assets | ₹1,082.9 Cr | ₹1,016.87 Cr | ₹877.08 Cr | ₹792.97 Cr |
| Non-current Assets | ₹318.7 Cr | ₹336.32 Cr | ₹308.57 Cr | ₹271.98 Cr |
| Current Assets | ₹764.21 Cr | ₹680.55 Cr | ₹568.52 Cr | ₹520.99 Cr |
| Property, Plant & Equipment | ₹243.67 Cr | ₹243.04 Cr | ₹240.64 Cr | ₹233.96 Cr |
| Inventories | ₹444.6 Cr | ₹330.71 Cr | ₹229.07 Cr | ₹207.85 Cr |
| Trade Receivables | ₹83.79 Cr | ₹88.84 Cr | ₹94.31 Cr | ₹97.31 Cr |
| Cash & Equivalents | ₹70.67 Cr | ₹87.63 Cr | ₹75.5 Cr | ₹37.98 Cr |
| Equity (Net Worth) | ₹689.37 Cr | ₹648.67 Cr | ₹610.66 Cr | ₹573.35 Cr |
| Equity Share Capital | ₹19 Cr | ₹19 Cr | ₹19 Cr | ₹19 Cr |
| Borrowings (Non-current) | ₹55.34 Lakh | ₹1.61 Cr | ₹2.83 Cr | ₹40.32 Lakh |
| Borrowings (Current) | ₹121.18 Cr | ₹109.52 Cr | ₹105.48 Cr | ₹104.81 Cr |
| Total Debt (computed) | ₹121.73 Cr | ₹111.13 Cr | ₹108.31 Cr | ₹105.21 Cr |
| Current Liabilities | ₹388.03 Cr | ₹363.05 Cr | ₹260.6 Cr | ₹216.43 Cr |
| Total Liabilities | ₹393.53 Cr | ₹368.2 Cr | ₹266.42 Cr | ₹219.62 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | -₹13.91 Cr | ₹26.88 Cr | ₹74.72 Cr | ₹38.36 Cr | ₹17.05 Cr |
| Investing Cash Flow | ₹3.46 Cr | -₹4.05 Cr | -₹27.4 Cr | -₹2.88 Cr | -₹19.87 Cr |
| Financing Cash Flow | -₹6.51 Cr | -₹10.62 Cr | -₹9.81 Cr | -₹1.67 Cr | -₹22.23 Cr |
| Capital Expenditure | ₹3.01 Cr | ₹7.75 Cr | ₹26.77 Cr | ₹2.48 Cr | ₹1.1 Cr |
| Free Cash Flow (computed) | -₹16.92 Cr | ₹19.13 Cr | ₹47.95 Cr | ₹35.88 Cr | ₹15.95 Cr |
| Dividends Paid | ₹3.8 Cr | ₹3.8 Cr | ₹3.8 Cr | ₹3.8 Cr | ₹3.8 Cr |
| Net Change in Cash | -₹16.96 Cr | ₹12.21 Cr | ₹37.52 Cr | ₹33.81 Cr | -₹25.05 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹45.69 Cr | ₹65.96 Cr | ₹39.77 Cr | ₹280.17 Cr | ₹49.37 Cr | ₹36.87 Cr | ₹32.19 Cr | ₹243.88 Cr | ₹43.04 Cr | ₹31.74 Cr | ₹22.57 Cr | ₹235.28 Cr |
| Other Income | ₹2.38 Cr | ₹1.74 Cr | ₹1.93 Cr | ₹1.76 Cr | ₹4.04 Cr | ₹47.82 Lakh | ₹6.63 Lakh | ₹13.94 Lakh | ₹43.75 Lakh | ₹3.74 Lakh | ₹6.15 Lakh | ₹11.7 Lakh |
| Total Income | ₹48.07 Cr | ₹67.7 Cr | ₹41.7 Cr | ₹281.94 Cr | ₹53.41 Cr | ₹37.35 Cr | ₹32.26 Cr | ₹244.01 Cr | ₹43.48 Cr | ₹31.78 Cr | ₹22.63 Cr | ₹235.4 Cr |
| Cost of Materials Consumed | ₹67.7 Cr | ₹101.2 Cr | ₹20.55 Cr | ₹108.24 Cr | ₹100.62 Cr | ₹84.78 Cr | -₹52.27 Lakh | ₹62.67 Cr | ₹59.02 Cr | ₹8.35 Cr | ₹5.66 Cr | ₹69.42 Cr |
| Purchases of Stock-in-Trade | ₹1.87 Cr | ₹1.02 Cr | ₹27.7 Lakh | ₹4.35 Cr | ₹86.05 Lakh | ₹5.21 Cr | ₹3.75 Cr | ₹2.69 Cr | ₹2.56 Cr | ₹2.41 Cr | ₹4.08 Cr | ₹1.97 Cr |
| Changes in Inventories | -₹56.62 Cr | -₹73.12 Cr | -₹7.95 Cr | ₹23.8 Cr | -₹85.95 Cr | -₹77.5 Cr | ₹9.24 Cr | ₹57.55 Cr | -₹50.14 Cr | ₹3.37 Cr | -₹5.51 Cr | ₹51.36 Cr |
| Employee Benefit Expense | ₹3.48 Cr | ₹11.14 Cr | ₹9.66 Cr | ₹9.05 Cr | ₹5.51 Cr | ₹10.26 Cr | ₹8.17 Cr | ₹6.37 Cr | ₹7.08 Cr | ₹5.93 Cr | ₹7.85 Cr | ₹7.13 Cr |
| Finance Costs | ₹2.94 Cr | ₹4.18 Cr | ₹3.3 Cr | ₹2.89 Cr | ₹1.1 Cr | ₹3.37 Cr | ₹2.94 Cr | ₹2.24 Cr | ₹1.06 Cr | ₹2.84 Cr | ₹2.44 Cr | ₹2.76 Cr |
| Depreciation & Amortisation | ₹1.02 Cr | ₹97.5 Lakh | ₹97.5 Lakh | ₹97.5 Lakh | ₹1.32 Cr | ₹82.5 Lakh | ₹82.5 Lakh | ₹82.5 Lakh | ₹98.12 Lakh | ₹76 Lakh | ₹76 Lakh | ₹76 Lakh |
| Other Expenses | ₹22.65 Cr | ₹16.88 Cr | ₹10.05 Cr | ₹95.83 Cr | ₹24.62 Cr | ₹6.62 Cr | ₹5 Cr | ₹77.53 Cr | ₹20.04 Cr | ₹5.9 Cr | ₹4.96 Cr | ₹68.37 Cr |
| Total Expenses | ₹43.04 Cr | ₹62.28 Cr | ₹36.86 Cr | ₹245.13 Cr | ₹48.07 Cr | ₹33.56 Cr | ₹29.4 Cr | ₹209.88 Cr | ₹40.6 Cr | ₹29.55 Cr | ₹20.25 Cr | ₹201.78 Cr |
| Profit Before Exceptional Items & Tax | ₹5.03 Cr | ₹5.42 Cr | ₹4.84 Cr | ₹36.8 Cr | ₹5.34 Cr | ₹3.79 Cr | ₹2.86 Cr | ₹34.13 Cr | ₹2.87 Cr | ₹2.22 Cr | ₹2.38 Cr | ₹33.62 Cr |
| Exceptional Items | ₹1.26 Cr | ₹2.69 Cr | ₹0 | ₹2.06 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹94.9 Lakh | ₹2.5 Cr | ₹0 | ₹0 |
| Profit Before Tax | ₹6.29 Cr | ₹8.1 Cr | ₹4.84 Cr | ₹38.87 Cr | ₹5.34 Cr | ₹3.79 Cr | ₹2.86 Cr | ₹34.13 Cr | ₹3.82 Cr | ₹4.72 Cr | ₹2.38 Cr | ₹33.62 Cr |
| Total Tax Expense | ₹2.5 Cr | ₹87.28 Lakh | ₹64.11 Lakh | ₹65.97 Lakh | ₹62.73 Lakh | ₹1.14 Cr | -₹2.75 Lakh | ₹24.53 Lakh | ₹61.5 Lakh | ₹76.57 Lakh | ₹34.53 Lakh | ₹22.01 Lakh |
| Net Profit | ₹3.79 Cr | ₹7.23 Cr | ₹4.2 Cr | ₹38.21 Cr | ₹4.71 Cr | ₹2.66 Cr | ₹2.89 Cr | ₹33.89 Cr | ₹3.21 Cr | ₹3.96 Cr | ₹2.03 Cr | ₹33.4 Cr |
| Other Comprehensive Income | ₹33.72 Lakh | ₹9.15 Lakh | -₹8.75 Lakh | -₹8 Lakh | -₹68.11 Lakh | -₹11.69 Lakh | -₹10.96 Lakh | -₹12.42 Lakh | ₹94.27 Lakh | ₹56,000 | -₹42.55 Lakh | ₹0 |
| Total Comprehensive Income | ₹4.13 Cr | ₹7.32 Cr | ₹4.11 Cr | ₹38.13 Cr | ₹4.03 Cr | ₹2.54 Cr | ₹2.78 Cr | ₹33.76 Cr | ₹4.15 Cr | ₹3.96 Cr | ₹1.61 Cr | ₹33.4 Cr |
| EBITDA (computed) | ₹8.99 Cr | ₹10.57 Cr | ₹9.12 Cr | ₹40.67 Cr | ₹7.75 Cr | ₹7.99 Cr | ₹6.63 Cr | ₹37.2 Cr | ₹4.92 Cr | ₹5.82 Cr | ₹5.58 Cr | ₹37.15 Cr |
| Basic EPS | ₹2.17 | ₹3.80 | ₹2.16 | ₹20.06 | ₹0.00 | ₹1.34 | ₹1.46 | ₹17.77 | ₹2.18 | ₹2.09 | ₹0.85 | ₹17.58 |
| Diluted EPS | ₹2.17 | ₹3.80 | ₹2.16 | ₹20.06 | ₹0.00 | ₹1.34 | ₹1.46 | ₹17.77 | ₹2.18 | ₹2.09 | ₹0.85 | ₹17.58 |
Shareholding Pattern of Nath Bio-Genes (India) Limited
As per the shareholding pattern filed with NSE for the quarter ended Mar 2026, promoters hold 45.60%, foreign institutional investors hold 0.23%, domestic institutional investors hold 0.01%, retail and other public shareholders hold 54.17% of Nath Bio-Genes (India) Limited. The company had 33,031 shareholders on record.
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Promoters | 45.60% | 45.60% | 45.60% | 45.60% | 45.60% | 45.60% |
| Public | 54.40% | 54.40% | 54.40% | 54.40% | 54.40% | 54.40% |
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 45.60% | 45.60% | 45.60% | 45.60% | 41.05% | 40.86% | 41.79% | 40.72% | 40.69% | 51.23% | 51.39% |
| Public | 54.40% | 54.40% | 54.40% | 54.40% | 58.95% | 59.14% | 58.21% | 59.28% | 59.31% | 48.77% | 48.61% |
| Promoter change (YoY, %pts) | +0.00 | +0.00 | +0.00 | +4.55 | +0.19 | -0.93 | +1.07 | +0.03 | -10.54 | -0.16 | - |
Board & Governance of Nath Bio-Genes (India) Limited
As per the corporate governance filing with NSE for the quarter ended 31-MAR-2026, the board of Nath Bio-Genes (India) Limited has 7 directors - 4 independent and 2 executive. The board is chaired by Satish Laxminarayan Kagliwal.
| Director | Position | On board since | Listed boards |
|---|---|---|---|
| Satish Laxminarayan Kagliwal | Executive Director · MD · Chairperson | 2000-03-29 | 3 |
| Jeevanlata Nandkishor Kagliwal | Executive Director | 2019-05-30 | 2 |
| Vadla Nagbhushanam | Non-Executive - Independent Director | 2020-11-07 | 1 |
| Madhukar Dhondiraj Deshpande | Non-Executive - Independent Director | 2021-02-10 | 2 |
| Hitesh Rajnikant Purohit | Non-Executive - Independent Director | 2022-03-30 | 3 |
| Akash Kagliwal | Non-Executive - Non Independent Director | 2023-04-22 | 3 |
| Payal Dilipkumar Jain | Non-Executive - Independent Director | 2025-07-11 | 1 |
| Committee | Members |
|---|---|
| Audit Committee | Madhukar Dhondiraj Deshpande (Chairperson), Vadla Nagbhushanam, Satish Laxminarayan Kagliwal |
| Nomination and remuneration committee | Hitesh Rajnikant Purohit (Chairperson), Vadla Nagbhushanam, Madhukar Dhondiraj Deshpande |
| Stakeholders Relationship Committee | Madhukar Dhondiraj Deshpande (Chairperson), Vadla Nagbhushanam, Satish Laxminarayan Kagliwal |
| Risk Management Committee | Satish Laxminarayan Kagliwal (Chairperson), Vadla Nagbhushanam, Hitesh Rajnikant Purohit |
| Corporate Social Responsibility Committee | Vadla Nagbhushanam (Chairperson), Madhukar Dhondiraj Deshpande, Satish Laxminarayan Kagliwal |
Charges & Borrowings of Nath Bio-Genes (India) Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Jul 2025 | Others | ₹5 Cr | Open |
| 13 Jun 2025 | Others | ₹80 Lakh | Open |
| 21 Jun 2024 | Axis Bank Limited | ₹10.25 Lakh | Open |
| 03 Apr 2024 | Hdfc Bank Limited | ₹57.78 Lakh | Open |
| 06 Mar 2024 | Hdfc Bank Limited | ₹31.46 Lakh | Open |
Total charge records: 21 View all charges
Employees and EPFO Compliance at Nath Bio-Genes (India) Limited
Nath Bio-Genes (India) Limited has a workforce of 417 employees as of Apr 02, 2024.
Employee Count & EPFO Data of Nath Bio-Genes (India) Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Nath Bio-Genes (India) Limited
GSTIN & GST Filing Data of Nath Bio-Genes (India) Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Nath Bio-Genes (India) Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Nath Bio-Genes (India) Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Nath Bio-Genes (India) Limited
MSME Payment Delays by Nath Bio-Genes (India) Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Nath Bio-Genes (India) Limited
Subsidiaries & Group Companies of Nath Bio-Genes (India) Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Nath Bio-Genes (India) Limited with ownership details.
MCA Filings & Documents of Nath Bio-Genes (India) Limited
MCA Filings & Documents of Nath Bio-Genes (India) Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Nath Bio-Genes (India) Limited
Recent News on Nath Bio-Genes (India) Limited
Frequently Asked Questions about Nath Bio-Genes (India) Limited
Nath Bio-Genes (India) Limited is an active public limited company in the agriculture sector based in Aurangabad, Maharashtra, India. It was incorporated on 14 July 1993 (33+ years old) and is registered under CIN L01110MH1993PLC072842. Listed on BSE: 537291 and NSE: NATHBIOGEN. The company has 417 employees.
Nath Bio-Genes (India) Limited reported revenue of ₹369.45 Cr for FY 2025 (up 11.00% YoY).
The current directors of Nath Bio-Genes (India) Limited are:
- Vadla Nagabhushanam
- Akash Nandkishor Kagliwal
- Jeevanlata Nandkishor Kagliwal
- Madhukar Dhondiraj Deshpande
- Hitesh Rajnikant Purohit
- Dhiraj Rajesh Rathi
- Satish Laxminarayan Kagliwal
- Payal Dilipkumar Jain
- Amol Arunrao Gupta
The primary industry of Nath Bio-Genes (India) Limited is agriculture. The company specifically operates in seed production and distribution. The company is currently active in this sector.
Yes. Nath Bio-Genes (India) Limited is listed on both BSE (code: 537291) and NSE (symbol: NATHBIOGEN).
Nath Bio-Genes (India) Limited can be reached at the registered office: Nath House Nath Road, Aurangabad, Maharashtra, India – 431005, or through the website nathbiogenes.com.